RWP
TTOO

Ridgecrest Wealth Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Ridgecrest Wealth Partners’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$1K – 103
2022
Q3 		$1K Hold
2
– – ﹤0.01% 98
2022
Q2 		$2K Hold
2
– – ﹤0.01% 106
2022
Q1 		$5K Hold
2
– – ﹤0.01% 109
2021
Q4 		$5K Hold
2
– – ﹤0.01% 122
2021
Q3 		$9K Hold
2
– – ﹤0.01% 114
2021
Q2 		$12K Hold
2
– – 0.01% 109
2021
Q1 		$16K Buy
+2
New +$21.2K 0.02% 91

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Ridgecrest Wealth Partners's TTOO Position: Q4 2022 in Review

Ridgecrest Wealth Partners sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 2 shares — an estimated $1K sold.

Ridgecrest Wealth Partners first reported a position in TTOO in Q1 2021 and held it in 7 quarters. The position peaked at $16K in Q1 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Ridgecrest Wealth Partners reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Ridgecrest Wealth Partners sold 2 T2 Biosystems, Inc shares in Q4 2022, an estimated $1K.
  • Ridgecrest Wealth Partners first reported a position in T2 Biosystems, Inc in Q1 2021 and held it in 7 quarters.
  • Ridgecrest Wealth Partners's T2 Biosystems, Inc position peaked at $16K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Ridgecrest Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.